Cargando…
The distribution of alternative agents for targeted radiotherapy within human neuroblastoma spheroids.
This study aims to select the radiopharmaceutical vehicle for targeted radiotherapy of neuroblastoma which is most likely to penetrate readily the centre of micrometastases in vivo. The human neuroblastoma cell line NB1-G, grown as multicellular spheroids, provided an in vitro model for micrometasta...
Autores principales: | Mairs, R. J., Angerson, W., Gaze, M. N., Murray, T., Babich, J. W., Reid, R., McSharry, C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971876/ https://www.ncbi.nlm.nih.gov/pubmed/2003981 |
Ejemplares similares
-
131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.
por: Gaze, M. N., et al.
Publicado: (1992) -
Incorporation of iododeoxyuridine in multicellular glioma spheroids: implications for DNA-targeted radiotherapy using Auger electron emitters.
por: Neshasteh-Riz, A., et al.
Publicado: (1997) -
The uptake and retention of metaiodobenzyl guanidine by the neuroblastoma cell line NB1-G.
por: Mairs, R. J., et al.
Publicado: (1991) -
Modification of meta-iodobenzylguanidine uptake in neuroblastoma cells by elevated temperature.
por: Armour, A., et al.
Publicado: (1994) -
Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions.
por: Cunningham, S. H., et al.
Publicado: (1998)